Published in Clin J Am Soc Nephrol on April 30, 2009
A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. Transplantation (2015) 1.44
Recipient-related predictors of kidney transplantation outcomes in the elderly. Clin Transplant (2013) 0.90
The role of kidney-pancreas transplantation in diabetic kidney disease. Curr Diab Rep (2010) 0.80
Transplantation: kidney or kidney-pancreas transplant for the uremic diabetic? Nat Rev Nephrol (2009) 0.75
Simultaneous pancreas-kidney transplantation: lessons learned from the initial experience of a single center in Korea. Ann Surg Treat Res (2014) 0.75
Kidney Transplantation in the Diabetic Patient. J Clin Med (2015) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA (2003) 3.33
Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22
Mortality assessment for pancreas transplants. Am J Transplant (2004) 2.12
Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol (1997) 2.09
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol (2003) 1.85
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant (2005) 1.68
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg (2000) 1.16
The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy. A case series. Ophthalmology (1994) 1.12
Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis (2003) 1.07
Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation (1997) 1.05
Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival. Am J Transplant (2005) 1.03
Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol (2008) 1.02
Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant (2001) 1.02
Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance. Am J Kidney Dis (2006) 0.99
Bladder vs enteric drainage in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant (2005) 0.97
Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant. Br J Ophthalmol (2000) 0.95
Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation (1995) 0.90
Pancreas transplantation improves vascular disease in patients with type 1 diabetes. Diabetes Care (2004) 0.90
Trends in organ donation and transplantation in the United States, 1996-2005. Am J Transplant (2007) 0.89
Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes (2004) 0.89
Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis (2002) 0.88
Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes (2001) 0.88
What happens to the kidney in an SPK transplant when the pancreas fails due to a technical complication? Clin Transplant (2008) 0.84
Infectious complications following 72 consecutive enteric-drained pancreas transplants. Transpl Int (2006) 0.82
Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation (2007) 0.81
Incidence of intraabdominal infection in a consecutive series of 40 enteric-drained pancreas transplants with FK506 and MMF immunosuppression. Transpl Int (2000) 0.79
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52
Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92
Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int (2010) 2.57
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry (2006) 2.50
25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis (2008) 2.36
Increased fructose associates with elevated blood pressure. J Am Soc Nephrol (2010) 2.01
Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care (2009) 1.61
25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol (2009) 1.17
Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant (2006) 1.09
Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis (2012) 1.05
Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant (2007) 1.03
Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.03
Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes. Transplantation (2011) 1.02
The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients. Transplantation (2013) 0.98
Relation of serum phosphorus levels to ankle brachial pressure index (from the Third National Health and Nutrition Examination Survey). Am J Cardiol (2010) 0.95
Trends in immune function assay (ImmuKnow; Cylex™) results in the first year post-transplant and relationship to BK virus infection. Nephrol Dial Transplant (2011) 0.94
Acute kidney injury in kidney transplantation. Curr Opin Nephrol Hypertens (2013) 0.94
Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol (2008) 0.93
The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression. Transplantation (2010) 0.93
Simultaneous pancreas-kidney versus deceased donor kidney transplant: can a fair comparison be made? Transplantation (2009) 0.92
An analysis of the lack of donor pancreas utilization from younger adult organ donors. Transplantation (2010) 0.92
Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. J Ren Nutr (2007) 0.92
Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials. Ther Adv Cardiovasc Dis (2009) 0.92
Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am J Med (2010) 0.91
Chronic viral hepatitis in kidney transplantation. Nat Rev Nephrol (2011) 0.91
Effectiveness of a chronic kidney disease clinic in achieving K/DOQI guideline targets at initiation of dialysis--a single-centre experience. Nephrol Dial Transplant (2006) 0.88
The risk of acute rejection and the influence of induction agents in lower-risk African American kidney transplant recipients receiving modern immunosuppression. Clin Transplant (2014) 0.86
Effect of salivary phosphate-binding chewing gum on serum phosphate in chronic kidney disease. Nephron Clin Pract (2013) 0.86
Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. Clin J Am Soc Nephrol (2010) 0.85
The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis (2009) 0.84
Kidney function and progression of coronary artery calcium in community-dwelling older adults (from the Rancho Bernardo Study). Am J Cardiol (2012) 0.83
Long-term impact of donor-recipient size mismatching in deceased donor kidney transplantation and in expanded criteria donor recipients. Transplantation (2010) 0.83
Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts. Clin Transpl (2011) 0.83
Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity. Am J Transplant (2004) 0.83
Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops. J Ocul Pharmacol Ther (2012) 0.82
Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Clin Chem Lab Med (2009) 0.82
Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era. Transplantation (2009) 0.82
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia. J Investig Med (2015) 0.81
Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients. Transplantation (2009) 0.80
Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23. Am J Nephrol (2013) 0.80
Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients. Clin Nephrol (2013) 0.79
Long-term outcomes after coronary artery bypass grafting: preoperative kidney function is prognostic. J Thorac Cardiovasc Surg (2007) 0.79
Removing financial disincentives to organ donation: an acceptable next step? Clin J Am Soc Nephrol (2012) 0.79
The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease. Clin Nephrol (2012) 0.79
Preemptive retransplant for BK virus nephropathy without concurrent transplant nephrectomy. Transplantation (2010) 0.77
High dose intravenous immunoglobulin therapy for donor-specific antibodies in kidney transplant recipients with acute and chronic graft dysfunction. Transplantation (2014) 0.77
Standard criteria donor pancreas donation status is associated with improved kidney transplant outcomes. Clin Transplant (2009) 0.77
Page kidney causing reversible acute renal failure: an unusual complication of transplant biopsy. Transplantation (2005) 0.76
25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease. Clin Nephrol (2012) 0.75
Corticosteroid elimination in simultaneous liver-kidney transplantation recipients. Clin Transplant (2009) 0.75
Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases. Clin Transpl (2009) 0.75
Donor specific antibodies before and after kidney transplant: the University of Colorado Experience. Clin Transpl (2013) 0.75
Bortezomib use in chronic antibody-mediated allograft dysfunction: updates and additional cases. Clin Transpl (2010) 0.75
Live donor kidney - PAK versus SPK: how to decide? Curr Opin Organ Transplant (2017) 0.75
Current status of pancreas transplantation. Curr Opin Nephrol Hypertens (2016) 0.75
The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patients. Clin Pharmacokinet (2014) 0.75
High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts. Clin Transpl (2014) 0.75
Mineral Metabolites, Angiotensin II Inhibition and Outcomes in Advanced Chronic Kidney Disease. Am J Nephrol (2015) 0.75
De Novo Donor-Specific Antibody Formation in Tacrolimus-Based, Mycophenolate Versus Mammalian Target of Rapamycin Immunosuppressive Regimens. Exp Clin Transplant (2017) 0.75